Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 29OTHER 24NIH 9NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Multiple Myeloma 5Breast Neoplasms 5Wilms Tumor 4Prostatic Neoplasms 4Neoplasms 4Hematologic Neoplasms 4Burkitt Lymphoma 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Plasmablastic Lymphoma 3Pancreatic Neoplasms 3Lymphoma, Mantle-Cell 3Lymphoma 3HIV Infections 3Ependymoma 3Colorectal Neoplasms 3Astrocytoma 3Recurrence 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Melanoma 2Medulloblastoma 2Lymphoma, T-Cell 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Kidney Neoplasms 2Hodgkin Disease 2Head and Neck Neoplasms 2

Interventions

Cisplatin 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Triple Negative Breast Neoplasms × 30 days × Clear all
NCT02445391 2026-06-01

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
415 enrolled 15 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡